Biopool
This article was originally published in The Gray Sheet
Executive Summary
Signs a letter of intent to sell $2 mil. of its unregistered common stock to International Capital Partners, a Stamford, Connecticut- based firm that specializes in advising smaller-growth companies. Biopool plans to use proceeds from the financing "to pay down existing debt, for capital equipment and expenditures, to increase research and development, and to promote marketing efforts." The Ventura, California-based producer of test kits to assess and diagnose vascular system disorders expects to complete the financing by April 30.